Beneficial Effects of Long-Term Administration of an Oral Formulation of Angiotensin-(1–7) in Infarcted Rats
In this study was evaluated the chronic cardiac effects of a formulation developed by including angiotensin(Ang)-(1–7) in hydroxypropyl β-cyclodextrin (HPβCD), in infarcted rats. Myocardial infarction (MI) was induced by left coronary artery occlusion. HPβCD/Ang-(1–7) was administered for 60 days (7...
Main Authors: | Fúlvia D. Marques, Marcos B. Melo, Leandro E. Souza, Maria Claúdia C. Irigoyen, Rúben D. Sinisterra, Frederico B. de Sousa, Sílvia Q. Savergnini, Vinícius B. A. Braga, Anderson J. Ferreira, Robson A. S. Santos |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2012-01-01
|
Series: | International Journal of Hypertension |
Online Access: | http://dx.doi.org/10.1155/2012/795452 |
Similar Items
-
An orally active formulation of angiotensin-(1-7) produces an antithrombotic effect
by: Rodrigo Araujo Fraga-Silva, et al.
Published: (2011-01-01) -
The novel Mas agonist, CGEN-856S, attenuates isoproterenol-induced cardiac remodeling and myocardial infarction injury in rats.
by: Sílvia Q Savergnini, et al.
Published: (2013-01-01) -
ANGIOTENSIN II AND MYOCARDIAL INFARCTION
by: O. P. Shevchenko, et al.
Published: (2016-01-01) -
Beneficial Effects of Renin-Angiotensin System Blockers on Testicular Morphology
by: J. Alves-Pereira, et al.
Published: (2017-06-01) -
Treatment with angiotensin II in COVID-19 patients may not be beneficial
by: Susanne Rysz, et al.
Published: (2020-09-01)